Pub Date : 2025-12-12DOI: 10.1177/08830738251399266
Junxia Li, Yanqiang Chen, Qing Zhao
{"title":"Anti-Caspr2 Encephalitis Co-occurring With Moyamoya Disease: A Pediatric Case Report and Literature Review.","authors":"Junxia Li, Yanqiang Chen, Qing Zhao","doi":"10.1177/08830738251399266","DOIUrl":"https://doi.org/10.1177/08830738251399266","url":null,"abstract":"","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251399266"},"PeriodicalIF":1.6,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12DOI: 10.1177/08830738251387929
Mandie Wiebers Jensen, Margaret Wolf, Alicia Feryn, Thuan Nguyen, Isabel Katlaps, Joseph D Pinter
This study seeks to develop fine motor development growth curves for children with Down syndrome, specifically related to grasping and visual motor integration skills. A cross-sectional retrospective chart review was completed on a large cohort of children with Down syndrome from birth to 6 years of age who completed the Peabody Developmental Motor Scales-2nd Edition (PDMS-2). Although both fine motor and visual motor development were delayed in children with Down syndrome compared with typically developing peers, and a negative association between fine motor quotient and age was observed, grasping and visual motor integration raw scores increased with age. The Down syndrome-specific percentile curves developed here may enable providers to identify individuals requiring further investigation, and will be useful in future studies of factors that may influence fine motor development in Down syndrome. These data will also help parents better understand their children's development and interpret developmental test results.
{"title":"Fine Motor Development Growth Curves for Down Syndrome.","authors":"Mandie Wiebers Jensen, Margaret Wolf, Alicia Feryn, Thuan Nguyen, Isabel Katlaps, Joseph D Pinter","doi":"10.1177/08830738251387929","DOIUrl":"https://doi.org/10.1177/08830738251387929","url":null,"abstract":"<p><p>This study seeks to develop fine motor development growth curves for children with Down syndrome, specifically related to grasping and visual motor integration skills. A cross-sectional retrospective chart review was completed on a large cohort of children with Down syndrome from birth to 6 years of age who completed the Peabody Developmental Motor Scales-2nd Edition (PDMS-2). Although both fine motor and visual motor development were delayed in children with Down syndrome compared with typically developing peers, and a negative association between fine motor quotient and age was observed, grasping and visual motor integration raw scores increased with age. The Down syndrome-specific percentile curves developed here may enable providers to identify individuals requiring further investigation, and will be useful in future studies of factors that may influence fine motor development in Down syndrome. These data will also help parents better understand their children's development and interpret developmental test results.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251387929"},"PeriodicalIF":1.6,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145743041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-09DOI: 10.1177/08830738251398585
Keren Politi, Kfir Givony, Nitay Fraenkel, Patrice L Weiss, Amihai Rigbi, Daniel Bancovsky, Tally Lerman-Sagie
AimAmplitude-integrated electroencephalography (aEEG) is a method for continuous electrographic brain function monitoring. Despite evidence of aEEG relevancy in a range of clinical settings, its use has not yet been systematically tested in patients with chronic ventilation. We assessed the role of aEEG in the management of patients in a department of pediatric respiratory rehabilitation.MethodTwo hundred ninety aEEG readings from 116 patients over a period of 36 months were studied. aEEGs were performed on admission for all patients; 21 patients had repeated monitoring because of suspected seizures.ResultsMore than 92% of the patients had examinations that were feasible for interpretation. Seizures were noted in 29% of the aEEG readings at admission. A significant correlation was found between abnormal background activity and the presence of seizures. The aEEG obtained throughout hospitalization led to modification of treatment in 49% of patients including initiation of antiseizure medications in 20% of patients, avoidance of unnecessary treatment in 20% of patients, and transfer for advanced assessment in the primary hospital in 9% of patients.ConclusionThe results of this study reinforce the importance of using aEEG in chronically ventilated patients throughout rehabilitation. It is an important tool for accurate treatment and planning of the personal rehabilitation program.
{"title":"Implications of Amplitude-Integrated Electroencephalography Monitoring for Effective Treatment of Chronic Ventilated Children During the Rehabilitation Period.","authors":"Keren Politi, Kfir Givony, Nitay Fraenkel, Patrice L Weiss, Amihai Rigbi, Daniel Bancovsky, Tally Lerman-Sagie","doi":"10.1177/08830738251398585","DOIUrl":"https://doi.org/10.1177/08830738251398585","url":null,"abstract":"<p><p>AimAmplitude-integrated electroencephalography (aEEG) is a method for continuous electrographic brain function monitoring. Despite evidence of aEEG relevancy in a range of clinical settings, its use has not yet been systematically tested in patients with chronic ventilation. We assessed the role of aEEG in the management of patients in a department of pediatric respiratory rehabilitation<b>.</b>MethodTwo hundred ninety aEEG readings from 116 patients over a period of 36 months were studied. aEEGs were performed on admission for all patients; 21 patients had repeated monitoring because of suspected seizures.ResultsMore than 92% of the patients had examinations that were feasible for interpretation. Seizures were noted in 29% of the aEEG readings at admission. A significant correlation was found between abnormal background activity and the presence of seizures. The aEEG obtained throughout hospitalization led to modification of treatment in 49% of patients including initiation of antiseizure medications in 20% of patients, avoidance of unnecessary treatment in 20% of patients, and transfer for advanced assessment in the primary hospital in 9% of patients.ConclusionThe results of this study reinforce the importance of using aEEG in chronically ventilated patients throughout rehabilitation. It is an important tool for accurate treatment and planning of the personal rehabilitation program.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251398585"},"PeriodicalIF":1.6,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-09DOI: 10.1177/08830738251396190
Danielle Akinsanmi, Roshan Srinivasan, Yaacov Anziska, Steven Pavlakis
ObjectiveDysautonomia in neuromuscular junction disorders is not frequently reported and is not widely recognized. It has been linked to thymoma and several novel antibodies. Yet, autonomic instability can be found even when these features are absent. In MuSK-related myasthenia gravis, clinical autonomic signs have been found in a significant percentage.CaseWe present a report of MuSK-related myasthenia gravis in a teen that presented with strong dysautonomic symptoms, most notably orthostatic intolerance prior to onset of neuromuscular symptoms. The patient experienced a severe disease course because of concurrent autonomic and myasthenic crises, requiring intensive treatment for recovery.DiscussionThe patient is unique in syncopal and autonomic burden prior to myasthenia gravis diagnosis. It is difficult to explain dysautonomia in MuSK. However, current evidence along with this case suggests yet unknown roles with broader systemic effect tied to the MuSK protein.
{"title":"Syncope as a Presenting Symptom of MuSK-Associated Myasthenia Gravis: A Case Report.","authors":"Danielle Akinsanmi, Roshan Srinivasan, Yaacov Anziska, Steven Pavlakis","doi":"10.1177/08830738251396190","DOIUrl":"https://doi.org/10.1177/08830738251396190","url":null,"abstract":"<p><p>ObjectiveDysautonomia in neuromuscular junction disorders is not frequently reported and is not widely recognized. It has been linked to thymoma and several novel antibodies. Yet, autonomic instability can be found even when these features are absent. In MuSK-related myasthenia gravis, clinical autonomic signs have been found in a significant percentage.CaseWe present a report of MuSK-related myasthenia gravis in a teen that presented with strong dysautonomic symptoms, most notably orthostatic intolerance prior to onset of neuromuscular symptoms. The patient experienced a severe disease course because of concurrent autonomic and myasthenic crises, requiring intensive treatment for recovery.DiscussionThe patient is unique in syncopal and autonomic burden prior to myasthenia gravis diagnosis. It is difficult to explain dysautonomia in MuSK. However, current evidence along with this case suggests yet unknown roles with broader systemic effect tied to the MuSK protein.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251396190"},"PeriodicalIF":1.6,"publicationDate":"2025-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1177/08830738251392088
Mollie Lobl, Ellen J Silver, Elisa Muñiz, Blanche Benenson, Maria Valicenti-McDermott, Ruth Ek Stein
ObjectiveTo describe daily recreational screen time of 6-17-year-old children with and without autism and association of >2 hours screen time per day with the likelihood of meeting Centers for Disease Control and Prevention (CDC) recommendations of 1 hour/day physical activity, sleep 9-12 hours/night for ages 6-12 years, 8-10 hours/night for ages 13-17 years, and body mass index (BMI) <85%ile.MethodsSecondary analysis of 2020 National Survey of Children's Health. Children were divided into 2 groups: autism and neurotypical. Parents reported 6-17-year-old children's weekday recreational screen time, physical activity, sleep duration, weight, and height. Variables were dichotomized: screen time ≤2 hours / screen time >2 hours and met / did not meet each CDC recommendation. Descriptive statistics, χ2, and logistic regression were used. Data were weighted and adjusted for complex sampling.ResultsAmong 1030 children with autism and 24 205 neurotypical children aged ≥6 years, 68.6% vs 56.5% respectively had >2 hours of daily screen time (P = .001). More 6-12-year-olds with autism viewed >2 hours screen time daily (62.9% vs 48.0%, P < .001), but adolescents in the 2 groups did not differ. Those with autism and >2 hours screen time/weekday less often met CDC daily physical activity recommendation (16.2% vs 29.8%, P = .004), but this relationship held only among adolescents (11.0% vs 27.8%, P = .009). Among those 6-12 years old, with autism, screen time >2 hours/day was associated with a lower percentage with BMI ≥85%ile (22.2% vs 43.9%, P = .035). The autism group had no significant differences in sleep duration. In contrast, screen time >2 hours/day is associated with not meeting any of the guidelines among neurotypical children.ConclusionThese findings may have implications for counseling on realistic screen time habits.
目的描述6-17岁自闭症儿童和非自闭症儿童每天娱乐屏幕时间与达到疾病控制与预防中心(CDC)建议的1小时/天体力活动、6-12岁睡眠时间为9-12小时/夜、13-17岁睡眠时间为8-10小时/夜、体重指数(BMI)为2小时和达到/未达到CDC建议的可能性之间的关系。采用描述性统计、χ2和logistic回归分析。对复杂抽样的数据进行加权和调整。结果1030名自闭症儿童和24205名6岁以上神经正常儿童每日屏幕时间分别为68.6%和56.5% (P = .001)。更多的6-12岁自闭症儿童每天看屏幕2小时(62.9%比48.0%,P 2小时/工作日),更少的人达到疾病预防控制中心每日体育活动建议(16.2%比29.8%,P =。004),但这种关系仅在青少年中成立(11.0%对27.8%,P = 0.009)。在6-12岁的自闭症患者中,屏幕时间少于2小时/天与BMI≥85%的比例较低相关(22.2% vs 43.9%, P = 0.035)。自闭症组在睡眠时间上没有显著差异。相比之下,在神经正常的儿童中,每天看屏幕时间超过2小时与不符合任何指导方针有关。结论这些发现可能对现实屏幕时间习惯的咨询具有启示意义。
{"title":"Screen Time and Meeting Daily Health Recommendations in Children With and Without Autism.","authors":"Mollie Lobl, Ellen J Silver, Elisa Muñiz, Blanche Benenson, Maria Valicenti-McDermott, Ruth Ek Stein","doi":"10.1177/08830738251392088","DOIUrl":"https://doi.org/10.1177/08830738251392088","url":null,"abstract":"<p><p>ObjectiveTo describe daily recreational screen time of 6-17-year-old children with and without autism and association of >2 hours screen time per day with the likelihood of meeting Centers for Disease Control and Prevention (CDC) recommendations of 1 hour/day physical activity, sleep 9-12 hours/night for ages 6-12 years, 8-10 hours/night for ages 13-17 years, and body mass index (BMI) <85%ile.MethodsSecondary analysis of 2020 National Survey of Children's Health. Children were divided into 2 groups: autism and neurotypical. Parents reported 6-17-year-old children's weekday recreational screen time, physical activity, sleep duration, weight, and height. Variables were dichotomized: screen time ≤2 hours / screen time >2 hours and met / did not meet each CDC recommendation. Descriptive statistics, χ<sup>2</sup>, and logistic regression were used. Data were weighted and adjusted for complex sampling.ResultsAmong 1030 children with autism and 24 205 neurotypical children aged ≥6 years, 68.6% vs 56.5% respectively had >2 hours of daily screen time (<i>P</i> = .001). More 6-12-year-olds with autism viewed >2 hours screen time daily (62.9% vs 48.0%, <i>P</i> < .001), but adolescents in the 2 groups did not differ. Those with autism and >2 hours screen time/weekday less often met CDC daily physical activity recommendation (16.2% vs 29.8%, <i>P</i> = .004), but this relationship held only among adolescents (11.0% vs 27.8%, <i>P</i> = .009). Among those 6-12 years old, with autism, screen time >2 hours/day was associated with a lower percentage with BMI ≥85%ile (22.2% vs 43.9%, <i>P</i> = .035). The autism group had no significant differences in sleep duration. In contrast, screen time >2 hours/day is associated with not meeting any of the guidelines among neurotypical children.ConclusionThese findings may have implications for counseling on realistic screen time habits.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251392088"},"PeriodicalIF":1.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-08DOI: 10.1177/08830738251399269
Nicole M Castillo-Huerta, M Gabriel Delgado-Mosqueira, Alicia Diaz-Kuan, Carol Munayco Cortez, José Camones Huerta, Daniel Guillén-Pinto
IntroductionInfantile epileptic spasms syndrome (IESS) is a group of severe encephalopathies during infancy. In recent years, the search for genetic causes has gained importance. This study aimed to describe the genetic causes of IESS in children <2 years of age with access to diagnostic studies.Materials and MethodsA case series study was conducted in 6 pediatric neurology centers in Peru. Medical record data of children <2 years of age diagnosed with IESS were assessed.ResultsFifty-five cases were included, with a median age at diagnosis of 6 months, predominantly male (58.12%, n = 32), and from Lima (52.73%, n = 31). The predominant etiologic category was genetic-structural (38.18%, n = 21), with tuberous sclerosis standing out, followed by structural-congenital (30.90%, n = 17), genetic (27.27%, n = 15), and metabolic (3.63%, n = 2). All presented mixed neurodevelopmental delay, most of them of severe grade (63.64%, n = 35). The predominant electroencephalographic pattern was hypsarrhythmia (67.27%, n = 37). Vigabatrin was the most frequently used control medication (54.55%, n = 30). A total of 58.18% (n = 32) progressed to some type of epilepsy, whereas 23.64% (n = 13) controlled spasms. Twenty-four variants in 21 different genes and 2 chromosomal alterations were found.ConclusionsGenetic etiology was common and diverse in IESS. The genetic-structural category was the most frequent, followed by the structural-congenital category. A wide range of genetic variants was found in one-third of the cases. Prompt genetic identification in IESS is recommended to optimize treatment and improve the prognosis.
{"title":"Genetic Etiology of Infantile Spasms in Peruvian Children: A Multicenter Study.","authors":"Nicole M Castillo-Huerta, M Gabriel Delgado-Mosqueira, Alicia Diaz-Kuan, Carol Munayco Cortez, José Camones Huerta, Daniel Guillén-Pinto","doi":"10.1177/08830738251399269","DOIUrl":"https://doi.org/10.1177/08830738251399269","url":null,"abstract":"<p><p>IntroductionInfantile epileptic spasms syndrome (IESS) is a group of severe encephalopathies during infancy. In recent years, the search for genetic causes has gained importance. This study aimed to describe the genetic causes of IESS in children <2 years of age with access to diagnostic studies.Materials and MethodsA case series study was conducted in 6 pediatric neurology centers in Peru. Medical record data of children <2 years of age diagnosed with IESS were assessed.ResultsFifty-five cases were included, with a median age at diagnosis of 6 months, predominantly male (58.12%, n = 32), and from Lima (52.73%, n = 31). The predominant etiologic category was genetic-structural (38.18%, n = 21), with tuberous sclerosis standing out, followed by structural-congenital (30.90%, n = 17), genetic (27.27%, n = 15), and metabolic (3.63%, n = 2). All presented mixed neurodevelopmental delay, most of them of severe grade (63.64%, n = 35). The predominant electroencephalographic pattern was hypsarrhythmia (67.27%, n = 37). Vigabatrin was the most frequently used control medication (54.55%, n = 30). A total of 58.18% (n = 32) progressed to some type of epilepsy, whereas 23.64% (n = 13) controlled spasms. Twenty-four variants in 21 different genes and 2 chromosomal alterations were found.ConclusionsGenetic etiology was common and diverse in IESS. The genetic-structural category was the most frequent, followed by the structural-congenital category. A wide range of genetic variants was found in one-third of the cases. Prompt genetic identification in IESS is recommended to optimize treatment and improve the prognosis.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251399269"},"PeriodicalIF":1.6,"publicationDate":"2025-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145708031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04DOI: 10.1177/08830738251398573
Viviane Ugalde, Bill Rosen, Sophia Andrews, Lindsay Hagler, Alex Heisler, Ellese Lupori, Jackilen Shannon
Recurrent concussion (RC) studies, especially in young children, are limited and provide conflicting results. We studied 505 children sustaining concussions presenting to an outpatient concussion clinic over a 2-year period, ages 5-18, of which 207 were RCs. Recovery time was defined by days to return to play (RTP), return to learn (RTL), and headache recovery (HR). Recovery was not affected by age at first concussion. Neither loss of consciousness nor posttraumatic amnesia were more frequent in RC. The number of concussions was associated with prolonged HR, P = .03. Prolonged RTP (P = .002) and HR (P = .006) were associated with a longer duration of prior concussion recovery time. Prolonged RTL was associated with a shorter interval between concussions, P = .01. RC was associated with a higher number of total symptoms on initial presentation, endorsed affective symptomology, fatigue and headache, and a history of premorbid self-reported headaches and anxiety. HR was associated with a prior history of self-reported anxiety and depression in RC, whereas, in first concussions (FC) only anxiety was associated. Sleep disturbance on initial presentation was associated with HR in both groups. Although recovery from FC and those with RC exhibit broad variation, RC demonstrates differences in recovery, indicating a need for greater awareness of clinical recovery in this group. Definitions of full recovery from concussion are evolving. Further study of concussion recovery is needed, especially in children with RC.
{"title":"Retrospective, Observational Study of Recovery in Pediatric Recurrent Concussions.","authors":"Viviane Ugalde, Bill Rosen, Sophia Andrews, Lindsay Hagler, Alex Heisler, Ellese Lupori, Jackilen Shannon","doi":"10.1177/08830738251398573","DOIUrl":"https://doi.org/10.1177/08830738251398573","url":null,"abstract":"<p><p>Recurrent concussion (RC) studies, especially in young children, are limited and provide conflicting results. We studied 505 children sustaining concussions presenting to an outpatient concussion clinic over a 2-year period, ages 5-18, of which 207 were RCs. Recovery time was defined by days to return to play (RTP), return to learn (RTL), and headache recovery (HR). Recovery was not affected by age at first concussion. Neither loss of consciousness nor posttraumatic amnesia were more frequent in RC. The number of concussions was associated with prolonged HR, <i>P</i> = .03. Prolonged RTP (<i>P</i> = .002) and HR (<i>P</i> = .006) were associated with a longer duration of prior concussion recovery time. Prolonged RTL was associated with a shorter interval between concussions, <i>P</i> = .01. RC was associated with a higher number of total symptoms on initial presentation, endorsed affective symptomology, fatigue and headache, and a history of premorbid self-reported headaches and anxiety. HR was associated with a prior history of self-reported anxiety and depression in RC, whereas, in first concussions (FC) only anxiety was associated. Sleep disturbance on initial presentation was associated with HR in both groups. Although recovery from FC and those with RC exhibit broad variation, RC demonstrates differences in recovery, indicating a need for greater awareness of clinical recovery in this group. Definitions of full recovery from concussion are evolving. Further study of concussion recovery is needed, especially in children with RC.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251398573"},"PeriodicalIF":1.6,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We report a pediatric case of encephalomyeloradiculoneuropathy (EMRN) presenting with elevated lactate levels in cerebrospinal fluid (CSF) and magnetic resonance spectroscopy (MRS), indicating astrocytic metabolic dysfunction. A 7-year-old girl developed fever, headache, and altered consciousness, initially diagnosed as acute disseminated encephalomyelitis (ADEM). Brain and spinal magnetic resonance imaging revealed multifocal lesions in the cerebral white matter and cervical spinal cord. CSF lactate was markedly elevated (4.06 mmol/L), and MRS demonstrated a lactate peak (7.95 mM). Nerve conduction studies revealed absent F waves and decreased reflexes, indicating peripheral nerve involvement. Anti-lactosylceramide antibodies were detected. The patient showed limited response to corticosteroids and IVIG but improved after plasma exchange. Follow-up MRS confirmed lactate normalization. This case underscores the relevance of astrocytic inflammation in EMRN pathogenesis and utility of MRS in identifying astrocytic metabolic impairment. MRS may differentiate EMRN from ADEM, especially in atypical or treatment-refractory presentations, allowing earlier diagnosis and targeted therapeutic strategies.
{"title":"Pediatric Encephalomyeloradiculoneuropathy With High Lactate in Cerebrospinal Fluid and Magnetic Resonance Spectroscopy: A Case Report.","authors":"Kenta Ochiai, Taku Omata, Kentaro Sano, Tatsuro Mutoh, Jun-Ichi Takanashi","doi":"10.1177/08830738251400135","DOIUrl":"https://doi.org/10.1177/08830738251400135","url":null,"abstract":"<p><p>We report a pediatric case of encephalomyeloradiculoneuropathy (EMRN) presenting with elevated lactate levels in cerebrospinal fluid (CSF) and magnetic resonance spectroscopy (MRS), indicating astrocytic metabolic dysfunction. A 7-year-old girl developed fever, headache, and altered consciousness, initially diagnosed as acute disseminated encephalomyelitis (ADEM). Brain and spinal magnetic resonance imaging revealed multifocal lesions in the cerebral white matter and cervical spinal cord. CSF lactate was markedly elevated (4.06 mmol/L), and MRS demonstrated a lactate peak (7.95 mM). Nerve conduction studies revealed absent F waves and decreased reflexes, indicating peripheral nerve involvement. Anti-lactosylceramide antibodies were detected. The patient showed limited response to corticosteroids and IVIG but improved after plasma exchange. Follow-up MRS confirmed lactate normalization. This case underscores the relevance of astrocytic inflammation in EMRN pathogenesis and utility of MRS in identifying astrocytic metabolic impairment. MRS may differentiate EMRN from ADEM, especially in atypical or treatment-refractory presentations, allowing earlier diagnosis and targeted therapeutic strategies.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251400135"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
BackgroundMeningitis remains a major cause of morbidity and mortality among children aged 0-14 years, especially in low- and middle-income countries, despite global advances in vaccines and health care.MethodsBased on Global Burden of Disease (GBD) 2021 data, we assessed meningitis-related prevalence, mortality, and disability-adjusted life years (DALYs) in children aged 0-14 across 204 countries from 1990 to 2021, stratified by age, sex, region, and Socio-demographic Index (SDI). Trends were evaluated using Estimated Annual Percentage Change.ResultsFrom 1990 to 2021, global prevalence, deaths, and DALYs declined by 52.0%, 69.2%, and 69.1%, respectively. The highest burden in 2021 was observed in Sub-Saharan Africa and South Asia. Disease burden showed wide geographic variation and was inversely correlated with SDI. Leading attributable risks included malnutrition and behavioral factors.ConclusionsAlthough meningitis burden has decreased globally, regional disparities persist. Sustained vaccination, health system strengthening, and targeted interventions in high-burden areas remain critical to reducing preventable childhood deaths and disabilities.
{"title":"Global, Regional, and National Burden of Meningitis in Children Aged 0-14 Years From 1990 to 2021: Trends and Disparities Based on the Global Burden of Disease Study.","authors":"Shuangjian Yang, Changqin Pu, Congcong Deng, Xuexue Bai, Chenxin Tian, Wentai Zhang, Renzhi Wang, Mengqi Chang, Ming Feng","doi":"10.1177/08830738251399249","DOIUrl":"https://doi.org/10.1177/08830738251399249","url":null,"abstract":"<p><p>BackgroundMeningitis remains a major cause of morbidity and mortality among children aged 0-14 years, especially in low- and middle-income countries, despite global advances in vaccines and health care.MethodsBased on Global Burden of Disease (GBD) 2021 data, we assessed meningitis-related prevalence, mortality, and disability-adjusted life years (DALYs) in children aged 0-14 across 204 countries from 1990 to 2021, stratified by age, sex, region, and Socio-demographic Index (SDI). Trends were evaluated using Estimated Annual Percentage Change.ResultsFrom 1990 to 2021, global prevalence, deaths, and DALYs declined by 52.0%, 69.2%, and 69.1%, respectively. The highest burden in 2021 was observed in Sub-Saharan Africa and South Asia. Disease burden showed wide geographic variation and was inversely correlated with SDI. Leading attributable risks included malnutrition and behavioral factors.ConclusionsAlthough meningitis burden has decreased globally, regional disparities persist. Sustained vaccination, health system strengthening, and targeted interventions in high-burden areas remain critical to reducing preventable childhood deaths and disabilities.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251399249"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1177/08830738251396193
Tuğba Acehan, Yağmur Harputlu Yamak, Şeyma Gürbüz, Ruken Demirkol Tunca, Yusuf Selman Çelik, Ayşe Kaçar Bayram, Ayşegül Efe, Bahadır Konuşkan
AimOur study aims to explore the relationship between anxiety, depressive symptoms, and family functioning about quality of life in children diagnosed with neurofibromatosis type 1.MethodsA total of 51 participants, including 24 children in the neurofibromatosis type 1 group and 27 age- and gender-matched controls, aged between 8 and 18 years, were included. A pediatric neurologist confirmed each neurofibromatosis type 1 diagnosis. A semi-structured clinical interview (KSADS-PL) and psychometric evaluation were performed by a unique child psychiatrist. A sociodemographic form and psychometric scales assessing family functioning, quality of life, and children's anxiety and depressive symptoms were administered.ResultsAttention-deficit hyperactivity disorder and/or specific learning disorder were identified in 12 cases (50.0%). Parent-reported psychosocial subscores and total quality of life scores were significantly lower in the neurofibromatosis type 1 group compared with controls. Affective involvement subscores in family functioning were significantly higher in the neurofibromatosis type 1 group than in controls. The total quality of life scores reported by both children and parents, along with parent-reported psychosocial quality of life subscores, showed a moderate positive correlation with age at neurofibromatosis type 1 diagnosis. In contrast to the control group, problem-solving subscores in family functioning in the neurofibromatosis type 1 group showed a moderate positive correlation with depression scores and a moderate negative correlation with child-reported psychosocial quality of life subscores. Additionally, in the neurofibromatosis type 1 group, general family functioning exhibited a moderate positive correlation with total anxiety scores and a moderate negative correlation with child-reported psychosocial quality of life subscores.ConclusionsAddressing family functioning and integrating psychosocial support into neurofibromatosis type 1 management may enhance adaptation, mental health, and long-term quality of life for affected children and their families.
{"title":"Family Functioning, Anxiety, and Depressive Symptoms and Their Impact on Quality of Life in Children With Neurofibromatosis Type 1.","authors":"Tuğba Acehan, Yağmur Harputlu Yamak, Şeyma Gürbüz, Ruken Demirkol Tunca, Yusuf Selman Çelik, Ayşe Kaçar Bayram, Ayşegül Efe, Bahadır Konuşkan","doi":"10.1177/08830738251396193","DOIUrl":"https://doi.org/10.1177/08830738251396193","url":null,"abstract":"<p><p>AimOur study aims to explore the relationship between anxiety, depressive symptoms, and family functioning about quality of life in children diagnosed with neurofibromatosis type 1.MethodsA total of 51 participants, including 24 children in the neurofibromatosis type 1 group and 27 age- and gender-matched controls, aged between 8 and 18 years, were included. A pediatric neurologist confirmed each neurofibromatosis type 1 diagnosis. A semi-structured clinical interview (KSADS-PL) and psychometric evaluation were performed by a unique child psychiatrist. A sociodemographic form and psychometric scales assessing family functioning, quality of life, and children's anxiety and depressive symptoms were administered.ResultsAttention-deficit hyperactivity disorder and/or specific learning disorder were identified in 12 cases (50.0%). Parent-reported psychosocial subscores and total quality of life scores were significantly lower in the neurofibromatosis type 1 group compared with controls. Affective involvement subscores in family functioning were significantly higher in the neurofibromatosis type 1 group than in controls. The total quality of life scores reported by both children and parents, along with parent-reported psychosocial quality of life subscores, showed a moderate positive correlation with age at neurofibromatosis type 1 diagnosis. In contrast to the control group, problem-solving subscores in family functioning in the neurofibromatosis type 1 group showed a moderate positive correlation with depression scores and a moderate negative correlation with child-reported psychosocial quality of life subscores. Additionally, in the neurofibromatosis type 1 group, general family functioning exhibited a moderate positive correlation with total anxiety scores and a moderate negative correlation with child-reported psychosocial quality of life subscores.ConclusionsAddressing family functioning and integrating psychosocial support into neurofibromatosis type 1 management may enhance adaptation, mental health, and long-term quality of life for affected children and their families.</p>","PeriodicalId":15319,"journal":{"name":"Journal of Child Neurology","volume":" ","pages":"8830738251396193"},"PeriodicalIF":1.6,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}